Invention Grant
![Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors](/docs/US/2020-02-11/US10556908B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
-
Application No.: US16130801Application Date: 2018-09-13
-
Publication No.: US10556908B2Publication Date: 2020-02-11
- Inventor: Liangxing Wu , Joel R. Courter , Chunhong He , Jingwei Li , Liang Lu , Yaping Sun , Xiaozhao Wang , Wenqing Yao , Colin Zhang , Jincong Zhuo
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00
![Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors](/abs-image/US/2020/02/11/US10556908B2/abs.jpg.150x150.jpg)
Abstract:
The present invention is directed to imidazo[1,2-a]pyrazine derivatives of Formula I, or a pharmaceutically acceptable salt thereof, which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20190106426A1 IMIDAZOPYRAZINES AS LSD1 INHIBITORS Public/Granted day:2019-04-11
Information query
